Hong Kong Stock Market News | Lai Kai Pharmaceuticals-B (02105) rose more than 22%, hitting a new high for the year. Recently announced clinical cooperation with eli lilly and co on a new type of weight loss drug.
The stock price of Lai Kai Pharmaceutical-B (02105) rose by over 22%, reaching a high of HK$17.4, setting a new high for the year. As of the time of publication, it has increased by 22.48%, trading at HK$17, with a turnover of 0.178 billion Hong Kong dollars.
Eli Lilly's (LLY) Breakthroughs: Hedge Funds' New Healthcare Favorite
Jim Cramer on Eli Lilly and Company (LLY): 'It's Valuable'
Trump Nominates Marty Makary For FDA Commissioner
The Trader: Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop -- Barron's
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
